Ramtin Agah - 03 Apr 2026 Form 4 Insider Report for RenovoRx, Inc. (RNXT)

Reporting relationship: Chief Medical Officer, Director
Issuer ticker: RNXT
Reported as of: 03 Apr 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 07 Apr 2026, 20:00:02 UTC
Prior SEC filing: 22 Jan 2026
Source filing: View source filing
Reporting owner signature: /s/ Ramtin Agah

Key filing fact

Ramtin Agah filed Form 4 for RenovoRx, Inc. (RNXT) on 07 Apr 2026.

Key facts

This page summarizes Ramtin Agah's Form 4 filing for RenovoRx, Inc. (RNXT).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 07 Apr 2026, 20:00.

Change

Previous filing in this sequence was filed on 22 Jan 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001862617 Primary reporting owner

Agah Ramtin

Relationship: Chief Medical Officer, Director
Address: C/O RENOVORX, INC., 2570 W EL CAMINO REAL, SUITE 320, MOUNTAIN VIEW
Signature: /s/ Ramtin Agah
Signature date: 07 Apr 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

RNXT transaction Derivative

Stock Option

Award

Transaction value
Shares: +621,727
Change %
Price: $0.000000^*
Shares after: 621,727
Date: 03 Apr 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 621,727
Exercise price: $0.9800
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

On April 3, 2026, with the approval of the Compensation Committee of the Issuer's Board of Directors, the Reporting Person was granted stock options to purchase up to 621,727 shares of the Issuer's common stock (319,073 shares of which are underlying incentive stock options and 302,654 of which are underlying non-qualified stock options), with such options vesting over four years at a rate of 1/48 per month with no cliff, and with vesting commencing effective January 1, 2026. The options will only become exercisable when there is an effective registration statement covering the shares underlying the options. The options will become fully vested on January 1, 2030, and will expire on April 3, 2036.